Abivax SA

ABVX · Healthcare

$113.67

Market cap: 9.92B USDDividend yield: —
AdvanceIs it a good moment to buy Abivax SA? Ask Copenvest AIGet an Advance AI take on timing, risk, and what tracked investors are doing.Ask Copenvest AI

Loading chart…

News

Latest headlines for this stock

GlobeNewswireSep 1, 2026, 11:00 AM

NetraMark Strengthens Board of Directors with Appointment of Veteran Pharmaceutical Executive Dr. Keith Fournier

Business WireAug 4, 2026, 7:00 AM

Evexta Bio Announces Clinical Trial Collaboration and Supply Agreement with Roche to Evaluate Rupitasertib in Combination with a Selective Estrogen Receptor Degrader in Advanced / Metastatic Breast Cancer

GlobeNewswireJul 30, 2026, 8:05 PM

Abivax Announces Positive Pre-NDA Interaction with the FDA for Obefazimod

Simply Wall St.Jul 26, 2026, 8:07 AM

ABIVAX Société Anonyme (ENXTPA:ABVX) Adds Commercial Leaders, Is The Upside Already Priced In?

MT NewswiresJul 24, 2026, 9:47 AM

Morgan Stanley Adjusts Price Target on Abivax to $180 From $132, Maintains Overweight Rating